Market Cap 134.91B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 7.86
Forward PE 8.05
Profit Margin 12.42%
Debt to Equity Ratio 0.71
Volume 59,958,900
Avg Vol 39,788,496
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 24%
Beta 0.34
Analysts Sell
Price Target $29.20

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
Mithlorien
Mithlorien Jun. 27 at 2:11 AM
$PFE Nice close here, a man can dream. We should retest 25$ very soon as it's a simple standard retrace of the move down. I really like this company, poor little things that no one likes anymore are my favorite... cheap options!
0 · Reply
CNMI670
CNMI670 Jun. 27 at 1:10 AM
ACOG - Alpha Cognition: Opaleye Mgmt accumulation with Zunveyl post-approval RESOLVE Phase 4 data due 2027 - study designed to further evaluate the safety and tolerability profile of Zunveyl in patients with Alzheimer's disease. $LLY $BMY $ABBV $PFE $MRK
0 · Reply
frankster
frankster Jun. 27 at 12:28 AM
$PFE what's so fascinating about this company is they're probbaly one of the top beneficiaries of AI evolution but they're priced for disaster. Correction will come eventually and it'll be vicious but for now it's dead money with dividend. 🤷🏻‍♂️
1 · Reply
JBS_84
JBS_84 Jun. 26 at 10:36 PM
$PFE It's up today because it was oversold And the medical sector performed today.
0 · Reply
JBS_84
JBS_84 Jun. 26 at 10:34 PM
$PFE The 23.65 area I was mentioning yesterday was the panic bottom. Institutional accumulation.
0 · Reply
Daddy4
Daddy4 Jun. 26 at 10:21 PM
$PFE in the year 2000 PFE was a $300 BB company. They would quickly accumulate an additional $300 BB in acquisitions ranging from Warner Lambert, Upjohn, Wyeth, Array Pharma, Seagen, Metaera among others. A total of $600 Billion in capital assets over many household names and brands. Today we are at $130 BB. Had they merely retained the value of the assets we would be at $120. Double or triple that with meaning growth. 80 % of the capital assets from 25 years ago is gone. Once the largest pharma is now bait for the bigger fish. I’m a long time holder of this and am thoroughly disgusted with the value destruction. And on it goes. Phase III trials that go completely belly up. Lots of them. And to see the likes of AMGN. JNJ. MRK. And LLY all soar. We languish. It might be time to seek a strategic partner and relinquish the helm of this rudderless ship.
1 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 26 at 10:05 PM
$PFE Umm.... There was 51.5 million shares traded at 4:04 PM.. Wtf?
2 · Reply
Nitro111
Nitro111 Jun. 26 at 8:41 PM
$CRBU so is $PFE buying this or what? ⌛
0 · Reply
simonds
simonds Jun. 26 at 8:11 PM
$PFE They are trying to confuse us. This is not right. We now have to wait until next Monday for this trash to go down.
0 · Reply
_Crim_Jamer_
_Crim_Jamer_ Jun. 26 at 8:02 PM
$PFE why is it green?
0 · Reply
Latest News on PFE
Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 3:52 PM EDT - 2 days ago

Pfizer Declares Third-Quarter 2026 Dividend


Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 24, 2026, 10:51 AM EDT - 2 days ago

Pfizer dismissed from US states' drug price-fixing lawsuit


Pfizer (PFE) Shares Sink After Surprise CFO Exit

2026-06-18T18:35:11.000Z - 8 days ago

Pfizer (PFE) Shares Sink After Surprise CFO Exit


Pfizer reaffirms all components of FY26 guidance

2026-06-18T17:30:31.000Z - 8 days ago

Pfizer reaffirms all components of FY26 guidance


Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:52 AM EDT - 8 days ago

Pfizer CFO Dave Denton to step down, leave company in August


Pfizer Announces Chief Financial Officer Transition

Jun 18, 2026, 6:45 AM EDT - 8 days ago

Pfizer Announces Chief Financial Officer Transition


Pfizer says FDA approves expanded indication for Hympavzi

2026-06-08T10:51:57.000Z - 18 days ago

Pfizer says FDA approves expanded indication for Hympavzi


US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:49 AM EDT - 18 days ago

US FDA approves Pfizer's bleeding disorder drug for children


Pfizer presents results from Phase 2b studies of berobenatide

2026-06-07T22:00:49.000Z - 19 days ago

Pfizer presents results from Phase 2b studies of berobenatide


Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 20 days ago

Pfizer Transcript: Study update


Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 20 days ago

Pfizer Slides: Study update


Pfizer Press release: Study update

Jun 6, 2026, 11:00 AM EDT - 20 days ago

Pfizer Press release: Study update


Mailbag: A Follow-Up on Pfizer & Other Questions

May 30, 2026, 9:22 AM EDT - 27 days ago

Mailbag: A Follow-Up on Pfizer & Other Questions

AGNC LAND NLY PFFA


Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

May 5, 2026, 4:09 PM EDT - 7 weeks ago

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC


Pfizer CEO on AI-designed molecule, and race to use new tech

May 5, 2026, 4:02 PM EDT - 7 weeks ago

Pfizer CEO on AI-designed molecule, and race to use new tech


3 Dividend Stocks for May 2026

May 5, 2026, 11:30 AM EDT - 7 weeks ago

3 Dividend Stocks for May 2026

SYY WSO


Pfizer Earnings Call Transcript: Q1 2026

May 5, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Earnings Call Transcript: Q1 2026


Pfizer Earnings release: Q1 2026

May 5, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Earnings release: Q1 2026


Pfizer Quarterly report: Q1 2026

May 5, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Quarterly report: Q1 2026


Pfizer Slides: Q1 2026

May 5, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Slides: Q1 2026


Pfizer Posts Better-Than-Expected Revenue, Profit

May 5, 2026, 8:35 AM EDT - 7 weeks ago

Pfizer Posts Better-Than-Expected Revenue, Profit


Why selling these 3 dividend stocks could be a mistake

May 5, 2026, 7:05 AM EDT - 7 weeks ago

Why selling these 3 dividend stocks could be a mistake

EPD UPS


US FDA approves Pfizer, Arvinas' breast cancer drug

May 1, 2026, 12:37 PM EDT - 2 months ago

US FDA approves Pfizer, Arvinas' breast cancer drug

ARVN


Pfizer's blood cancer drug meets main goal in late-stage trial

Apr 29, 2026, 7:42 AM EDT - 2 months ago

Pfizer's blood cancer drug meets main goal in late-stage trial


Mithlorien
Mithlorien Jun. 27 at 2:11 AM
$PFE Nice close here, a man can dream. We should retest 25$ very soon as it's a simple standard retrace of the move down. I really like this company, poor little things that no one likes anymore are my favorite... cheap options!
0 · Reply
CNMI670
CNMI670 Jun. 27 at 1:10 AM
ACOG - Alpha Cognition: Opaleye Mgmt accumulation with Zunveyl post-approval RESOLVE Phase 4 data due 2027 - study designed to further evaluate the safety and tolerability profile of Zunveyl in patients with Alzheimer's disease. $LLY $BMY $ABBV $PFE $MRK
0 · Reply
frankster
frankster Jun. 27 at 12:28 AM
$PFE what's so fascinating about this company is they're probbaly one of the top beneficiaries of AI evolution but they're priced for disaster. Correction will come eventually and it'll be vicious but for now it's dead money with dividend. 🤷🏻‍♂️
1 · Reply
JBS_84
JBS_84 Jun. 26 at 10:36 PM
$PFE It's up today because it was oversold And the medical sector performed today.
0 · Reply
JBS_84
JBS_84 Jun. 26 at 10:34 PM
$PFE The 23.65 area I was mentioning yesterday was the panic bottom. Institutional accumulation.
0 · Reply
Daddy4
Daddy4 Jun. 26 at 10:21 PM
$PFE in the year 2000 PFE was a $300 BB company. They would quickly accumulate an additional $300 BB in acquisitions ranging from Warner Lambert, Upjohn, Wyeth, Array Pharma, Seagen, Metaera among others. A total of $600 Billion in capital assets over many household names and brands. Today we are at $130 BB. Had they merely retained the value of the assets we would be at $120. Double or triple that with meaning growth. 80 % of the capital assets from 25 years ago is gone. Once the largest pharma is now bait for the bigger fish. I’m a long time holder of this and am thoroughly disgusted with the value destruction. And on it goes. Phase III trials that go completely belly up. Lots of them. And to see the likes of AMGN. JNJ. MRK. And LLY all soar. We languish. It might be time to seek a strategic partner and relinquish the helm of this rudderless ship.
1 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 26 at 10:05 PM
$PFE Umm.... There was 51.5 million shares traded at 4:04 PM.. Wtf?
2 · Reply
Nitro111
Nitro111 Jun. 26 at 8:41 PM
$CRBU so is $PFE buying this or what? ⌛
0 · Reply
simonds
simonds Jun. 26 at 8:11 PM
$PFE They are trying to confuse us. This is not right. We now have to wait until next Monday for this trash to go down.
0 · Reply
_Crim_Jamer_
_Crim_Jamer_ Jun. 26 at 8:02 PM
$PFE why is it green?
0 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 26 at 8:01 PM
0 · Reply
EmbraceVolatility
EmbraceVolatility Jun. 26 at 7:57 PM
$PFE Need to close above 24.20.
2 · Reply
simonds
simonds Jun. 26 at 7:46 PM
$PFE This piece of trash should be below $20 if not much lower
0 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 26 at 7:40 PM
$PFE of course
0 · Reply
simonds
simonds Jun. 26 at 7:32 PM
$PFE Wants to go down. That is the normal trajectory of this piece of garbage
0 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 26 at 7:31 PM
$PFE here comes the weak close
0 · Reply
DidYouReadThis
DidYouReadThis Jun. 26 at 6:13 PM
Do you think $OTLK will go past a 7 billion market cap within 7 years? $REGN $PFE $MCK
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Jun. 26 at 5:59 PM
$PFE Lilly is up their entire revenue for the year in one day (again)... (almost 3/4 of a Pfizer) Im starting to think the market likes them more than us
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Jun. 26 at 5:35 PM
$PFE Even Moderna is running circles around us. I could have picked ANY stock but I just had to settle on this one. Literally anything else would have been better...
1 · Reply
mathko
mathko Jun. 26 at 5:31 PM
$PFE Long [email protected]. It looks like a pin near 24 unless a macro event occurs. I'd estimate: 24.00: 65% 24.50: 20% 23.50: 10% 25.00+: 5% The market keeps drifting around 24.05–24.15 recently rather than accelerating in either direction.
0 · Reply
ians
ians Jun. 26 at 5:16 PM
$IOVA A combo of Lifileucel + $PFE recently failed ADC for 2L+ NSCLC would definitely beat SOC docetaxel for pts. Refractory to CPIs. 👍 And IOVA is still cheap, trading below $2B MC 🤑. Bourla here's your chance to redeem yourself. 🤔☘️💎 "The median duration of response (mDOR) was not reached after a median follow up of 25.4 months. 26% Objective Response Rate Lifileucel Launch in Previously Treated Advanced NSCLC Expected in Second Half of 2027 Standard-of-care docetaxel monotherapy in patients with nonsquamous NSCLC previously treated with immune checkpoint inhibitors and chemotherapy has recently shown an ORR of 12.8% with an mDOR of 5.6 months and overall survival of 12.3 months, without any complete responses.2" https://finance.yahoo.com/news/iovance-biotherapeutics-reports-potential-best-120000464.html
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Jun. 26 at 5:08 PM
$PFE - Thank you Computershare for reminding me of my dividend reinvestment and its price 😤
0 · Reply